Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Tevagrastim

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PurposeRecombinant granulocyte colony-stimulating factors (rG-CSFs), such as filgrastim, are administered to prevent… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2018
2018
PurposeFilgrastim, a recombinant human granulocyte-colony stimulating factor, is widely used to treat congenital and acquired… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Human recombinant granulocyte colony-stimulating factor (G-CSF), filgrastim (Neupogen; Amgen, Thousand Oaks, CA, USA), has been… Expand
Is this relevant?
2015
2015
BACKGROUND Filgrastim biosimilars have recently been introduced into clinical practice. To date biosimilars have demonstrated… Expand
Is this relevant?
2015
2015
The recombinant human granulocyte colony-stimulating factor (G-CSF) known as filgrastim (Tevagrastim®, Ratiograstim®, Biograstim… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2013
2013
Purpose Granulocyte colony-stimulating factors (G-CSFs), filgrastim and lenograstim, are recognised to be useful in accelerating… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
![Graphic][1] Introduction Human recombinant G-CSF Filgrastim (Neupogen) has been widely used for the mobilization of CD34… Expand
Is this relevant?
2012
2012
Human recombinant granulocyte colony stimulating factor (rhG-CSF) is widely used in hematology and oncology for the treatment of… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Review
2011
Review
2011
Biopharmaceuticals were copies of endogenous human proteins developed in the mid-1990s that were characterized by complex three… Expand
  • table 1
  • table 2
Is this relevant?